We are live on
!
Find out more
KFS
Kurt F. Somerville Portfolio holdings
AUM
$379M
1-Year Est. Return
19.42%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$402M
AUM Growth
+$154M
(+62%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
34.96%
Top 10 Holdings %
Top 10 Hldgs %
34.66%
Holding
133
New
31
Increased
71
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$5.69M |
| 2 |
Mastercard
MA
|
+$5.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$4.68M |
| 4 |
Canadian National Railway
CNI
|
+$4.64M |
| 5 |
Novartis
NVS
|
+$4.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$1.02M |
| 2 |
XEC
CIMAREX ENERGY CO
XEC
|
+$214K |
| 3 |
HUB.B
HUBBELL INC CL-B
HUB.B
|
+$202K |
| 4 |
Corning
GLW
|
+$152K |
| 5 |
Gilead Sciences
GILD
|
+$20.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.12% |
| 2 | Healthcare | 21.83% |
| 3 | Industrials | 18.28% |
| 4 | Energy | 9.56% |
| 5 | Consumer Staples | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
101
DELISTED
Unilever NV New York Registry Shares
UN
| $278K | 0.07% |
+7,130
| New | +$279K |
|
102
AB InBev
BUD
$161B
| $257K | 0.06% |
+2,290
| New | +$254K |
|
103
Verizon
VZ
$201B
| $247K | 0.06% |
5,305
| – | – |
|
104
Manulife Financial
MFC
$74.2B
| $244K | 0.06% |
12,788
| – | – |
|
105
Intuit
INTU
$85.6B
| $237K | 0.06% |
2,575
| – | – |
|
|
COL
106
DELISTED
Rockwell Collins
COL
| $227K | 0.06% |
2,685
| – | – |
|
107
Phillips 66
PSX
$82.5B
| $225K | 0.06% |
3,139
| – | – |
|
108
Idexx Laboratories
IDXX
$44.9B
| $222K | 0.06% |
+3,000
| New | +$210K |
|
109
Danaher
DHR
$140B
| $214K | 0.05% |
3,720
| – | – |
|
110
Medtronic
MDT
$111B
| $212K | 0.05% |
+2,930
| New | +$204K |
|
111
Walt Disney
DIS
$172B
| $200K | 0.05% |
+2,115
| New | +$191K |
|
112
Eaton
ETN
$150B
| $191K | 0.05% |
+2,810
| New | +$185K |
|
113
VF Corp
VFC
$7.16B
| $171K | 0.04% |
+2,427
| New | +$161K |
|
114
Gevo
GEVO
$363M
| – | – |
-3
| Closed | -$7K |
|
|
XEC
115
DELISTED
CIMAREX ENERGY CO
XEC
| – | – |
-1,694
| Closed | -$214K |
|
|
HUB.B
116
DELISTED
HUBBELL INC CL-B
HUB.B
| – | – |
-1,675
| Closed | -$202K |
|
Similar funds
NICM
CFG
MLFP
CSWG
EAM
PIM
AC
LFGO
Kurt F. Somerville's Q4 2014 Portfolio in Review
As of Q4 2014, Kurt F. Somerville held 133 positions worth $402M, up 62% from $248M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Kurt F. Somerville deployed $140M of net new capital in Q4 2014, opening 31 new positions and adding to 71 existing holdings. Its largest new stake was CDK Global, Inc.: 46,231 shares worth $1.89M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was GSK, an estimated $1.02M trimmed.
- Kurt F. Somerville's largest Q4 2014 buy was CDK Global, Inc.: 46,231 shares worth $1.89M.
- Kurt F. Somerville added most to CVS Health in Q4 2014, an estimated $5.69M increase.
- Kurt F. Somerville's biggest Q4 2014 reduction was GSK, cutting an estimated $1.02M.
- Kurt F. Somerville fully exited CIMAREX ENERGY CO in Q4 2014, selling an estimated $214K.
- Kurt F. Somerville's ten largest holdings make up 35% of its $402M portfolio in Q4 2014.
- Kurt F. Somerville opened 31 new positions and closed 3 in Q4 2014.
- Kurt F. Somerville's portfolio value rose 62% quarter-over-quarter to $402M.
Based on Kurt F. Somerville's 13F filing for Q4 2014, filed 13 Feb 2015.